Sunshine Biopharma (SBFM) Shares Outstanding (Diluted) (2017 - 2026)
Sunshine Biopharma (SBFM) Shares Outstanding (Diluted) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 9.03 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 1.18 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 422.40 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 47.20 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 18.03 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.18 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 103.40 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 506.00 Mn |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | 392,524.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 392,524.00 |
| Dec 31, 2025 | 392,524.00 |
| Sep 30, 2025 | 392,524.00 |
| Jun 30, 2025 | 360,465.00 |
| Mar 31, 2025 | 270,329.00 |
| Dec 31, 2024 | 70,175.00 |
| Sep 30, 2024 | 126,756.00 |
| Jun 30, 2024 | 4,973.00 |
| Mar 31, 2024 | 3,207.00 |
| Dec 31, 2023 | 1,217.00 |
| Sep 30, 2023 | 1,285.00 |
| Jun 30, 2023 | 1,268.00 |
| Mar 31, 2023 | 1,102.00 |
| Dec 31, 2022 | 759.00 |
| Sep 30, 2022 | 944.00 |
| Jun 30, 2022 | 792.00 |
| Mar 31, 2022 | 264.00 |
| Dec 31, 2021 | 131.00 |
| Sep 30, 2020 | 3.00 |
| Jun 30, 2020 | 3.00 |